Effects of 8-Methoxypsoralen and Ultraviolet Radiation on Human Lymphoid Cells in Vitro  by Kraemer, Kenneth H. et al.
0022-202X/8l/7602-0080$02.00/0 
THE JOURNAL OF lNVESTIGATIVE DERMATOLOGY , 76:80-87, 1981 
Copyright © 1981 by The Williams & Wilkins Co. 
Vol. 76, No. 2 
Printed in U.S.A. 
Effects of 8-Methoxypsoralen and Ultraviolet Radiation on Human 
Lymphoid Cells in Vitro 
KENNETH H. KRAEMER, M.D., HAYWOOD L. WATERS, B.S., LAWRENCE F. COHEN, M.D., 
NICOLAE C. POPESCU, PH.D., SUZANNE c. AMSBAUGH, B.S., JOSEPH A. DIPAOLO, PH.D., 
DANIEL GLAUBIGER, M.D. , PH.D., OWEN L. ELLINGSON, B.S., AND ROBERT E. TARONE, PH.D. 
Laboratory of Molecular Carcinogenesis (KK & HW); Pediatric Oncology Branch (LC & DG); Laboratory of Biology (NP, SA, & JD); 
Biometry Branch (RT), National Cancer Institute, Bethesda, Maryland and Electrooptics Branch, Division of Electronic Products (OE), 
Bureau of Radiologic Health, Food and Drug Administration, Roclwille, Maryland, U.S.A. 
Oral 8-methoxypsoralen (8-MOP) plus high-intensity 
long-wavelength ultraviolet radiation (UV -A) is used 
clinically to induce remissions of psoriasis and mycosis 
fungoides. Leukocytes in 8-MOP containing blood re-
ceive UV -A exposure when circulating through the der-
mis during therapy. The present study utilizes an in vitro 
assay system to permit quantitation and correlation of 
multiple biological and physical alterations in human 
lymphoid cells induced by 8-MOP plus UV-A treatment. 
Additive inhibition oflymphoid cell DNA synthesis by 8-
MOP (0.01 to 1~tg/ml) plus UV -A (1,000 to 29,000 J /m2 ) 
was accompanied by a synergistic potentiation of cell 
killing in the therapeutic exposure range. Reduction in 
tritiated thymidine eHTdR) incorporation to 65-70% of 
control value was associated with normal survival; while 
3HTdR incorporation of less than 50% of control induced 
by any 8-MOP plus UV-A combination tested was asso-
ciated with less than 10% survival. 8-MOP-DNA-cross-
lin.ks were detected by the alkaline elution assay only 
when 3HTdR incorp9ra~ion was reduced to less than 50% 
of control. The relative number of crosslinks increased 
proportionately with further 8-MOP plus UV -A-induced 
reduction in 3HTdR incorporation. 8-MOP plus UV-A 
induced at most approximately a 2-fold increase in sister 
chromatid exchanges (SCE) per chromosome in lympho-
cytes or lymphoblastoid cells. Increasing 8-MOP plus 
UV-A exposure resulted in marked toxicity with few 
cells progressing to second division metaphases and no 
further increase in SCE's per chromosome. Addition of 
13-cis retinoic acid (1~tg/ml) to the lymphoblastoid cells 
prior to 8-MOP plus UV -A treatment did not significantly 
alter the 3HTdR incorporation or cell survival. These 
studies demonstrate that in vitro exposure of human 
lymphoid cells to therapeutic levels of 8-MOP and UV -A 
may decrease cellular DNA synthesis, produce DNA 8-
MOP interstrand cross-links, reduce cell viability and 
induce small increases in sister chromosome exchanges. 
Oral 8:methoxypsoralen (8-MOP) plus high-intensity long-
wavelength ultraviolet radiation (UV-A) is being used clinically 
to induce remissions in psoriasis [1-3] and in mycosis fungoides 
[4]. 8-MOP when activated by UV-A binds to DNA forming 8-
MOP-DNA adducts [5] which in turn inhibit cellular prolifer-
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ation. Because the 8-MOP is present in the blood following oral 
administration [6,7] and UV-A penetrates through the epider-
mis [8], circulating blood cells might be subjected to 8-MOP-
DNA photoreactions. Previously, decreased DNA synthesis in 
circulating leukocytes from some psoriasis patients receiving 8-
MOP plus UV-A (PUVA) therapy was reported [9,10]. 
An in vitro assay system was developed to facilitate exami-
nation of multiple effects of 8-MOP and UV-A on fresh human 
lymphocytes and on transformed lymphocyte cell lines [7]. The 
studies presented here permit quantitation and correlation of 
multiple 8-MOP plus UV -A induced biological and physical 
alterations in the same assay system. This investigation dem-
onstrates that inhibition of DNA synthesis by UV-A and 8-
MOP is additive, extends the observation of dose dependence 
of inhibition of DNA synthesis and of cell survival to low 
therapeutic concentrations of 8-MOP, and describes the rela-
tionship of DNA synthesis inhibition to cell killing and to DNA-
8-MOP cross-link induction. Additional observations report 
sister chromatid exchange induction in vitro by 8-MOP plus 
UV -A and the lack of significant effect of 13-cis retinoic acid on 
8-MOP plus UV-A induced DNA synthesis inhibition and cell 
killing. 
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MATERIALS AND METHODS 
Cells 
Fresh lymphocytes were obtained from normal donors by leukopho-
resis (performed by the Red Cross Blood Bank, Washington, D.C.) and 
further purified by flotation in lymphocyte separation medium (LSM 
solution, Litton Bionetics, Kensington, MD). An Epstein-Barr virus-
transformed lymphoblastoid cell line (E-1) from a normal donor was 
obtained from Dr. Alan Andrews, Dermatology Branch, National Can-
cer Institute. The cells were cultured in RPMI 1640 medium (Grand 
Island Biological Co., Buffalo, NY or B & B Laboratories, Baltimore, 
MD) supplemented with 17% fetal calf serum (Gibco, or HEM Re-
search, Rockville, MD) without antibiotics, in closed 490 cm2 plastic 
t issue culture roller flasks (Corning No. 25130) at 37°C with continuous 
rotation. This procedure results in a mild blastogenic response in the 
fresh lymphocytes [11]. The stock lymphoblastoid cells were fed at 1 to 
3 day intervals to maintain exponential growth. 
8-MOP Treatment 
For irradiation 1,000,000 cells/ml (lymphocytes) or 200,000 cells/ml 
(E-1) in 75 cm2 plastic flasks (Costar Plastics) were suspended in a salt 
solution consisting of the salts and glucose present in RPMI 1640 
medium (NaCl 6.0 g/1, KCI 0.4 g/1, Sodium Bicarbonate 2.0 g/1, 
NazHP0,.7HzO 1.5 g/1 Calcium Nitrate.4Hz0 0.1 g/1, Magnesium Sul-
fate . 7Hz0.0.1 g/1, and Glucose 2.9 g/1). 8-MOP (a gift from Paul B. 
Elder Co., Bryan, OH) was stored frozen in liquid nitrogen in the dark 
as a 1 mg/ml stock solution in absolu te ethanol. The 8-MOP was 
diluted in salt solution immediately before addition to the cell suspen-
sion and incubated with the cells at 37°C for at least 15 min before UV-
A exposure. All manipulations were performed under gold fluorescen t 
lamp (Westinghouse F40 Go, or General Electric F20 Tl2 Go) illumi-
nat ion. 
Irradiation 
T he flasks containing the cell suspensions were placed horizontally 
in a holder above a plate glass filter (6-mm thick) which was suspended 
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above 4 parallel UV -A fluorescent lamps (FR40T12-PUVA-a gift from 
Phototherapy Lighting Products Group, GTE Sylvania, Danvers, MA). 
Identical type lamps are used in clinical photo-chemotherapy [1-3] 
without the plate glass ftlter. 
Figure 1 shows the spectral irradiance of the unftltered "PUV A" 
lamp and of the lamp with the plate glass ftlter. Included is a calculation 
of the predicted spectral irradiance using pigmented or unpigmented 
epidermis (data from reference 8) as a ftlter to mimic the ftltering effect 
of the epidermis on radiation impinging upon lymphocytes in the 
dermis. Thus, the plate glass filter eliminates radiation below 320 nm 
which is normally ftltered by the epidermis in vivo. 
The lamp source was described previously [7]. The calculated irra-
diance within the flask was 22.5 J/m2/s with an estimated uncertainty 
of ± 25%. Radiant intensity varied approximately 9% across the expo-
sure field. The cells were kept in suspension during irradiation and 
exposed to different portions of the field by shaking the plate glass at 
approximately 40 revolutions per min. Control unirradiated suspensions 
were placed in an opaque box on the same shaker. 
DNA Synthesis 
Five replicate 1 ml samples of the cell suspension from each flask 
were placed in tightly capped 12 x 75 mm plastic tubes (Falcon No. 
2058) with 10 J.!Ci/ml methyl-tritiated thymidine eHTdR) (21-36 Ci/ 
mM ICN Pharmaceuticals, Irvine, CA) and incubated in the dark for 2 
hr in a 37°C water bath. 3HTdR incorporation into DNA was measured 
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FIG 1. Filtering of "PUV A" fluorescent lamp radiation by plate glass 
or by epidermis. The spectral irradiance of Sylvania FR40T12 PUV A 
lamp operated at 115 v was measured at a distance of 2 meters with 
(- ) and without (-) 6-mm plate glass ftlter. Predicted spectral irradi-
ance using unpigmented epidermis (- · -·-) or pigmented epidermis 
( ... ) as a ftlter (data from reference 8) is also shown. Further details in 
Materials and Methods. 
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FIG 2. Effects of pretreatment at different temperatures on DNA 
synthesis in human lymphoblastoid cells. Cells were suspended in 
culture medium at the indicated temperature for 30 min, 3HTdR was 
added, and each culture medium was incubated for an additional 2 hr 
at 37° before harvesting. Further details in Materials and Methods. 
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by a modification [7] of the Millipore assay technique of Robbins et al 
[12]. Samples were dripped gently onto the Millipore ftlters, washed 
successively with saline, 5% trichloroacetic acid, and ethanol; vacuum 
dried, and counted in RPI Scintillator PPO-POPOP (Research Prod-
ucts International Corp., E lk Grove Village, IL) in Beckman model LS 
250 Liquid Scintillation System. In preliminary experiments (Fig 2), a 
temperature dependence of the rate of 3HTdR incorporation into the 
lymphoblastoid cells was noted. Greatest activity was measured at 37°, 
the highest temperature tested. Thus, subsequent experiments were 
performed with the cell suspensions maintained at 37 ± 3° by use of 
hot air heaters as monitored with a thermoprobe (Tele-Thermometer 
model 44TD with probe model 401, Yellow Springs Instrument Co., 
Yellow Spring, OH) . 
Statistical Analysis 
For each experiment the mean 3HTdR incorporation determinations 
were normalized to the untreated control value. Using the method of 
least squares, the curve y=a exp (bxc) was fit to the data for each 
concentration of 8-MOP where y denotes the normalized 3HTdR incor-
poration value and x denotes the dose of UV -A. At every exposure level 
of UV -A a linear regression analysis was performed using y as the 
dependent variable and x as the independent variable. 
Growth Curve Analysis 
Growth assays of lymphoblastoid cells: After irradiation a solution 
containing vitamins, amino acids, phenol red, and fetal bovine serum 
was added to each flask so that the fmal medium concentration was 1 
x RPMI 1640 with 17% fetal calf serum and 100,000 lyrnphoblastoid 
cells/ mi. The flasks were placed in a 37°C incubator with 5% C02 and 
95% relative humidity (Hotpack model 351920), in the dark for 4-14 
days without medium change. The concentration of viable cells was 
estimated daily by duplicate hemocytometer counts of trypan blue 
(Trypan Blue Stain 0.4% in normal saline, Grand Island Biological Co.) 
excluding cells. The standard deviation of the duplicate counts was 
generally less than 10% of the mean. Before treatment greater than 90% 
of the cells excluded trypan blue. 
Survival was estimated by a modification [13] of the method of 
Alexander and Mikulski [14]. The growth curve of the concentration of 
viable cells was extrapolated back to zero time along the exponentially 
increasing portion. This method measures the proportion of the treated 
cell population which survives with the capacity to proliferate at a 
normal rate. 
Microliter Well Growth Assay 
A modified limiting dilution assay was used (described in detail in 
reference 13). Briefly, serial dilutions of treated cells were innoculated 
into 24 wells of a microtiter plate (Linbro) (0.2 ml culture medium per 
well) and placed in a C02 incubator for 2-3 weeks. The wells were 
examined under an inverted microscope (Leitz, Diavert) for evidence 
of cell growth. The fraction of negative wells at each dilution served as 
a basis for determining the surviving fraction by the Poisson formula. 
Retinoic Acid Treatment 
13-cis-retinoic acid (Ro4-3780) was obtained from Roche Pharma-
ceuticals through Dr. G. Peck, Dermatology Branch, National Cancer 
Institute. Stock solution of 1 mg/ml in absolute ethanol was stored 
frozen in liquid nitrogen. The 13-cis retinoic acid was diluted in salt 
solution immediately before addition to the cell suspension and incu-
bated with the cells at 37° for 15 min prior to UV -A exposure. 
Sister Chromatid Exchange Determination 
Human leukocyte cultures were initiated using 12 ml RPMI 1640 
medium supplemented with 17% fetal bovine serum containing 500,000 
cells mi. Phytohemagglutinin (Gibco M form) was added at a concen-
tration of 0.1 ml per culture coincidentally with bromodeoxyuridine 
(BrdU) 30 1-1g/ ml. 
For the lyrnphoblastoid cell line BrdU 10 }.lg/ ml was added to 
complete culture medium containing 100,000 cells/ mi. 
All cultures were maintained in complete darkness and incubated at 
37° ·c, 72 hr for leukocytes and 48 hr for lymphoblastoid cells. Colcemid 
was added at concentrations of 0.055 !Lg/ml and 0.067 1-1g/ ml at 2 and 4 
hr before harvest of leukocytes or lyrnphoblasts, respectively. Cells 
were fixed in 3: 1 methanol glacial acetic acid and slides were prepared 
by a standard air dry method. 
Slides were processed for sister chromatid exchange analysis using a 
modification of Kornberg and Freelender's Giemsa staining technique 
[15]. 50 metaphases of each sample were scored. 
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Alkaline Elution 
Alkaline elution was done as previously described [16-18]. Cells were 
prelabeled with 2-14-C-thymidine ((0.02 J.LCi/ml, 60 mCi/mM) and were 
placed on ice immediately following UV -A exposure. Cells to be eval-
uated for DNA crosslinking were also exposed to x-irradiation (300R at 
0-4°). Cells were then layered on a poly vinyl chloride filter, 2 Jl porosity 
(Millipore Corp., Bedford, Mass.) by gravity filteration . Cells were lysed 
with 5 ml of a solution of sodium lauroylsarcosinate (0.2% w/v) (Sar-
kosyl, ICN Pharmaceuticals, Plainview, NJ) 2 M NaCl, 0.02 M ethyl-
enedinitrilo tetracetic acid (EDTA), pH 10. 
The residual DNA on the filter was eluted with a solution consisting 
of0.04 M H,-EDTA plus tetraporpyl ammonium hydroxide (RSA Corp., 
Ardsley, NY) 2% in water pH 12.1. The elution rate was 0.04 ± 0.003 
ml/min. Ninety minute fractions were collected, and mixed with 3.3 vol 
of scintillation fluid (Aquasol, New England Nuclear, Boston, MA) plus 
100 
~ 90 
w 
a: 
::> 80 
"' 0 ~ 70 
<( 
> ::> 60 
a: 
t: 50 <( 
z 
0 
;:: 40 
<( 
a: 
2 
a: 
0 
u ;; 20 
a: 
I? 
.<' 10 
0 
0 0.75 1.5 2.25 3.0 
UV- A EXPOSURE (J I m2 x 10- "l 
FIG 3. DNA synthesis in human lymphocytes after 8-MOP plus UV-
A. Relative effect of UV-A (0) and UV-A plus 0.0111g/ml 8-MOP (e) 
on 3HTdR incorporation in ,lymphocytes from 4 donors. Each point 
represents the mean CPM of the 5 replicate treated cultures divided by 
the mean CPM of the 5 replicate untreated cultures in the same 
experiment. The curves were derived by least squares analysis of the 
points. The curves for 0.1 Jlg/ml8-MOP plus UV -A and 111g/ml8-MOP 
plus UV-A are reproduced from reference 7. The curve for UV-A alone 
is significantly different from the O.Ol!Lg/ml 8-MOP plus UV-A curve 
at every UV-A exposure (p < 0.05). Further details as described in the 
text. 
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FIG 4. DNA synthesis in human lymphoblastoid cells after 8-MOP 
plus UV-A. Relative effect of UV-A (0 ) and UV-A plus 0.0111g/ml 8-
MOP (e) on 3HTdR incorporation in lymphoblastoid cell line E-1. 
Each point represents the mean CPM of 5 replicate treated cultures 
divided by the mean CPM of the 5 replicate untreated cultures in the 
same experiment. The curves for 0.1 J.Lg/ml 8-MOP plus UV-A and 1 
11g/ml 8-MOP plus UV-A are reproduced from reference 7. The curve 
for UV-A alone is significantly different from the 0.01 Jlg/ml 8-MOP 
plus UV-A curve at every UV-A exposure (p < 0.05) . Further details as 
described in the text. 
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0.75% (V /V) acetic acid to reduce chemiluminiesence. Residual radio-
activity on the fllter was solubilized by 1 N hydrochloric acid and heat 
(60°, 1 hr) followed by sodium hydroxide (0.4 N, 1 hr) and the same 
scintillation fluid was then added for counting. 
Calculation of Crosslink Coefficient 
The fraction of DNA retained on the fllter is calculated from the 
amount of the total DNA eluted in the timed fractions. For evaluation 
of crosslinking, both control and t'est cells are exposed to 300 R to 
induce single-strand breaks. When the DNA is subsequently denatured 
under alkaline conditions, control DNA elutes rapidly. Increased reten-
tion of DNA on the fllter from cells treated with PUV A plus 300 R 
indicates DNA crosslinking. 
The crosslink coefficient (}{,) is calculated according to the formula: 
[ 1- Ro]112 K c = -R' -1 1- 0 
where Ro is the fraction of DNA retained in the 300 R control sample 
and Ro' is the fraction of DNA retained in the PUV A plus 300 R treated 
sample both taken at a standard time after elution begins. The deri-
vation of this formula is found in references 17 and 18. 
RESULTS 
Thymidine Incorporation in Fresh Lymphocytes 
The relative effect of UV -A (0-29,000 J /m2) alone and follow-
ing 0.01 J.tg/ml 8-MOP on 3HTdR incorporation into lympho-
cytes in 11 experiments with four donors is shown in Fig 3. The 
3HTdR incorporation in the unirradiated cultures of these cells 
which had been slightly stimulated by 1 to 4 days incubation in 
medium containing fetal bovine serum ranged from 796 to 4,000 
cpm per 106 cells. The 0.01 J.tg/ml 8-MOP plus UV -A treatment 
caused a significant (p < 0.05) reduction in 3HTdR incorpora-
tion in comparison to that caused by UV-A alone at every 
exposure tested. Figure 3 also contains comparable data from 
reference 7 for lymphocytes treated with 0.1 j.tg/ml or 1.0 j.tg/ml 
8-MOP before UV -A exposure. The 0.01 J.Lg/ml 8-MOP result 
was significantly (p < 0.05) different from the 0.1 J.Lg/ml8-MOP 
data only for UV-A exposures of 15,000 and 29,000 J/m2 . 
Thymidine Incorporation in Lymphoblastoid Cells 
Figure 4 shows the relative effect of UV-A (0-29,000 J/m2) 
alone and following 0.01 J.tg/ml8-MOP on 3HTdR incorporation 
in 15 experiments with a lymphoblastoid cell line from a normal 
donor. The 3HTdR incorporation in unirradiated cultures 
ranged from 41,416 to 263,734 cpm/200,000 cells. The degree of 
inhibition of 3HTdR incorporation following exposure to UV -A 
plus 0.01 J.tg/ml 8-MOP was significantly different (p < 0.01) 
from that after UV-A alone at every exposure tested. Also 
shown are the results for similar data at 8-MOP concentrations 
of 0.1 J.tg/ml and 1 J.tg/ml from reference 7. There was no 
significant difference between the 0.01 J.tg/ml8-MOP curve and 
the previous 0.1 J.tg/ml 8-MOP curve for UV -A exposures of 
7,500 J/m2 or less. As with the lymphocytes (Fig 3), the 0.01 
J.tg/ml8-MOP curve was significantly different (p < 0.05) from 
the previous 0.1 J.tg/ml8-MOP curve only for UV-A exposures 
o£.15,000 and 29,000 J/m2 • 
Reductions in DNA synthesis were observed by treatment of 
lymphoblastoid cells with either UV -A or 8-MOP alone (Fig 4). 
For most combinations of 8-MOP and UV-A the effect of 
treatment with 8-MOP plus UV -A on inhibition of 3HTdR 
incorporation was approximately equal to the sum of the extent 
of inhibitions observed with 8-MOP and UV-A separately (Fig 
5). Evidence suggestive of a weak synergism was observed only 
with the highest combinations tested. The percent of inhibition 
of 3HTdR incorporation observed following combined treat-
ment with 0.1 J.tg/ml 8-MOP plus 15,000 J/m2 UV-A was ap-
proximately equal to the sum of the percent inhibition observed 
with the separate treatments irrespective of the sequence of the 
treatments (Table I). 
3HTdR incorporation increased to control levels by 48 hr 
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FIG 5. Additivity of DNA synthesis inhibition by 8-MOP plus UV-
A in human lymphoblastoid cells. The curves from Fig 4 were evaluated 
at each UV -A exposure for the percent inhibi tion of "HTdR incorpo-
ration and expressed as bars. The bar represent ing the inhibition of 
''HTdR incorporation observed by each exposure of UV -A alone was 
added on top of the bar representing inhibition observed by the 
appropriate concentration of 8-MOP a lone and placed next to the bar 
represent ing inhibition observed by the combination of 8-MOP plus 
UV-A. For aJJ except the highest combinations tested, the sum of the 
heights of the separate bars is not less than the heigh t of th e bar 
represent ing the combined treatment. 
TABLE L Effect of sequence of 8-MOP and UV-A treatments on 
lym.phoblastoid cell DNA synthesis 
Treatment 
"HTdR lncorpo- Inhibition of Crossl ink 
UV-A ration CPM ± "HTdR lncor- Coefficient 8-MOP g/ ml J / m' 2SE poration 
0 0 123,076 ± 9,334 Control 
0.1 0 95,763 ± 7,719 22% 0.000 
0 15,000 84,666 ± 3,084 31% O.Ql7 
0.1 after 15,000 53,775 ± 4,805 56% 0.000 
UV-A 
0.1 before 15,000 50,838 ± 7,639 59% 0.086 
UV-A 
after treatment in cul tures treated with 15,000 J im~ UV-A 
alone, 0.1 ~giml 8-MOP alone or UV-A followed by 8-MOP. In 
contrast, "HTdR incorporation progressively decreased in cul-
t ures treated with 0.1 ~giml 8-MOP followed by 15,000 Jim~ 
UV -A so that by 48 hr after treatment aHTdR incorporation 
was less than 5% of control cultures (data not shown) . 
The cell viability was not appreciably altered with respect to 
the untreated control cells by the 0.1 ~giml 8-MOP alone, the 
15,000 Ji m2 UV-A alone, or the treatment with 8-MOP after 
UV -A. In contrast, there was a marked inhibition of cell viability 
induced by the treatment with 8-MOP before UV-A (Fig 6). 
Measurements of DNA crosslinking by the alkaline elut ion 
technique revealed significant crosslinking only in the cells 
treated with 8-MOP before UV-A (Table I). 
DNA-8-MOP Crosslinhing 
Figure 7 shows the relationship between the 'JHTdR incor-
poration following 8-MOP (1.0, 0.1, or 0.01 ~giml) plus subse-
quent UV-A treatment and the relative number of 8-MOP-
DNA interstrand crosslinks induced. When aHTdR incorpora-
tion was less than 50% of control there was a dose-dependent 
increase in 8-MOP-DNA crosslinking detected. 
Cell Survival Studies 
Figure 8 shows sw·vival of lymphoblastoid cells after treat-
ment with UV-A or with 8-MOP (1.0, 0.1 , or 0.01 ~giml) plus 
UV-A. The results of 29 experiments are plotted. Survival was 
measured by extrapolat ion from growth curves (as in Fig 6) in 
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7 experiments, by growth in microtiter wells in 2 experiments 
and by both methods in 10 experiments. There was a UV -A 
dose-dependent decrease in survival at every 8-MOP concen-
tration. UV-A exposure of 7,500 J i m 2 following pretreatment 
with 1.0 ~giml , 0.1 ~giml or 0.01 J.Lgi ml 8-MOP resulted in 
survivals of 0.03%, 6%, and 80% respectively. Neit her 8-MOP 
treatment alone nor UV -A exposure alone significant ly reduced 
cell survival. 
The relationship between the inhibi t ion of 3HTdR incorpo-
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F1G 6. Viab ili ty of human lymphoblastoid cells after 8-MOP plus 
UV-A exposure. Log phase cells were treated with 0.1 JLg! ml 8-MOP 
before (•) or after (.a.) exposure to 15,000 J / m 2 UV-A. Control cells 
were untreated (0 ), or exposed only to 0.1 J!g/ ml 8-MOP (~) or to 
15,000 J / m2 UV-A (0). Hemocytometer coun ts of viable (trypan blue 
excl uding) cells were performed daily following treatment. Further 
deta ils in Materials and Methods. 
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FI G 7. Helationship of DNA synthesis inhibition after 8-MOP plus 
UV-A to DNA 8-MOP crosslink induction. Lymphoblastoid cells were 
incubated with 0.01 j!g/ ml (e) , 0.1 Jlg/ ml (.a.), l j!g/ ml (•), or no (0 ) 8-
MOP and exposed to UV-A. "HTdH incorporation was determined 
from the curves in Fig 4 for each combination of 8-MOP and UV-A. 
T he DNA crosslink coefficient was determined using the alkaline 
elu tion assay. Further details are described in Materials and Methods. 
84 KRAEMER ET AL 
100 ~~~· ~ 
.. ~ ~ ~ NOBMOP ~ ~ 
i e 
t 0 " • 
'\: 0.01 f<Q / ml e 10 
0 A 
0 
A 
A 0 c A Q) .. ~ 0 0 A 
Q) 
.9- .. 
~ .. 0 0 
·~ 
" 
::J 
(f) 
" A 
~ 
.. 
i 
.. 
0.1 A 0.1 f'g/ ml 
.. 
UV-A Exposure (J /m' x 10-•1 
FI G 8. Survival of human lymphoblastoid cells after 8-MOP plus 
UV-A. Log phase cells were treated with O.Olj.!g/rnl (0, e) , O.lj.!g/ ml 
(6, A) , 1 j.!g/ ml (0, •) , or no ('il, '9') 8-MOP and exposed to UV-A. 
Survival was measured by extrapolation from growth curves (closed 
symbols ) and by growth in micro titer wells (open symbols ). The curves 
were calculated by the method of least squares. Further details in 
Materials and Methods. 
ration induced by 8-MOP plus UV-A (from Fig 4) and ceil 
survival (from Fig 8) indicates that survival was unaffected at 
levels of 'lHTdR incorporation of 60 to 70% of control (Fig 9). 
aHTdR incorporation less than 60% of control was associated 
with decreased cell survival. The correlation coefficient between 
the log of the surviving fraction and the fraction of 3HTdR 
incorporation remaining was 0.91 over the linear portion of the 
curve. Similar survival was observed at a similar extent of 
3HTdR incorporation inhibition obtained by different combi-
nations of 8-MOP plus UV-A. Thus, 50% of control 3HTdR 
incorporation was observed with 1 t-tg/ rnl 8-MOP plus 3,000 J/ 
m
1 UV-A, with 0.11-Lg/ rnl 8-MOP plus 15,500 J / m 2 UV-A, and 
with 0.01 t-tg/ml 8-MOP plus 58,000 J/m2 UV-A and was asso-
ciated with approximately 0.5% survival with each combination. 
Effects of Retinoic Acid 
Preincu~ation of lymphoblastoid cells with 1 t-tg/rnl 13 cis-
retinoic acid was associated with a decrease ·in aHTdR incor-
poration under each of the 4 conditions shown in Fig lOA, 
however, this decrease was not significant at the 0.05 signifi-
cance level (p = 0.08). Survival was unaffected by preincubation 
with 13 cis retinoic acid prior to 8-MOP, UV-A, or 8-MOP plus 
UV-A treatment (Fig lOB). 
Induction of Sister Chromatid Exchanges 
The induction of sister chromatid exchanges in lymphocytes 
after treatment with 8-MOP plus UV-A was significantly in-
creased (Table II). Second division metaphases were analyzed 
for the frequency of sister chromatid exchanges. Treatment 
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with 0.01 t-tg/ml 8-MOP plus 7,500 J/m" UV-A resulted in 
approximately a 65% increase in the number of SCE's per 
metaphase and per chromosome. The lymphocyte cultures were 
also analyzed 'for the frequency of first, second, and third 
division metaphases on the basis of the Giemsa pattern. The 
frequency of first division metaphases increased and second 
division meta phases decreased after 8-MOP plus UV -A. The 
combined regime also increased SCE in lymphoblastoid cells 
(Table III). However, treatment with 0.1 t-tg/ rnl 8-MOP plus 
3,000 J/m2 UV-A resulted in an approximately 2-fold increase 
in SCE's per chromosome or per metaphase. 8-MOP alone (0.1 
t-tg/ml) or UV-A alone (15,000 J/m2) were ineffective in altering 
the number of SCE's. Treatment with 0.1 t-tg/rnl 8-MOP plus 
15,000 J /m2 UV -A substantially reduced the number of second 
division metaphases. 
DISCUSSION 
The in vitro assay system described approximates some of 
the conditions of 8-MOP plus UV -A on human lymphoid cells 
in vivo during photochemotherapy. It is designed to measure 
direct effects of 8-MOP plus UV-A. The UV-A radiation deliv-
ered to the cells in in vitro was ftltered to remove the short-
wave ultraviolet radiation which is absorbed by the epidermis 
before reaching the lymphoid cells circulating through the 
dermis in vivo. The plate glass used in these experiments 
resulted in a spectral distribution similar to that passing 
through pigmented epidermis at wavelengths below 330 nm 
(Fig 1). This short-wavelength ultraviolet radiation (in the UV-
B range) is more toxic to leukocytes than the UV-A [19] and 
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thus its removal is important in seeking to mimic the in vivo 
situation. The in vitro assay was performed at 37° for increased 
DNA synthesis (Fig 2) and to mimic the temperature of circu-
lating lymphoid cells. 8-MOP concentrations used were in the 
range measmed in the serum of patients undergoing photo-
chemotherapy (cited in reference 7). However, no attempt was 
made to study the effect of circulating metabolites of 8-MOP 
which are also present in patients [6], or other possible indirect 
effects of 8-MOP plus UV-A in vivo. UV-A exposure to circu-
lating lymphocytes has been estimated to be 1-5% of the skin 
sw·face dose (19]. T his estimate was based on assuming a 
cutaneous blood volume of 100-500 ml by analogy to experi-
ments in small mammals. With typical skin UV-A exposure of 
100,000 J/m~ (10 J / cm2) the circulating lymphocytes would be 
estimated to be receiving UV-A exposures on the order of 1,000 
to 5,000 Jim~. 
A rapid, dose-dependent inhibition of DNA synthesis oc-
curred with 8-MOP plus UV-A treatment of human lympho-
cytes (Fig 3) and a lymphoblastoid cell line (Fig 4). Scherer, 
Kern, and Braun-Falco [20] and Kruger, Christophers, and 
Schlark (21] measured DNA synthesis 3 days after 8-MOP plus 
UV -A treatment of phytohemagglutinin (PHA) stimulated leu-
kocytes. They found a qualitativiely sin1ilar dose-dependent 
inhibition of DNA synthesis for the combinnd treatment but 
no effect with 8-MOP or UVA alone. However, they did not 
measure immediate inhibition of DNA synthesis. In our studies 
decreased DNA synthesis was observed when measured in1-
mediately after treatment with 8-MOP or UV-A alone, but by 
48 hr, DNA synthesis had increased to the control level. 
The separate effects of 8-MOP and UV-A treatments on 
immediate inhibition of DNA synthesis were approximately 
additive (Fig 5) (for most combinations of 8-MOP and UV-A) 
and independent of the sequence of treatments (Table I). 8-
MOP in the dark is known to bind noncovalently with DNA 
[5]. UV -A alone has been shown to alter transfer RNA metab-
olism in bacteria [22]. However, t he inhibition of DNA synthesis 
induced by the lesion(s) resulting from treatment with 8-MOP 
alone or UV-A alone was nonlethal (Fig 8). Only in those 
cul tures treated with UV-A after 8-MOP was cell survival 
significantly altered (Fig 6). Further, only cells from those 
cultmes contained detectable DNA interstrand crosslinks. 
Smvival of lymphoblastoid cells after 8-MOP plus UV-A 
treatmet was markedly dose-dependent (Fig 8). Depending on 
the 8-MOP preincubation concentration, survival after a UV-A 
exposure of 3,500 J / m2 , presumably in the therapeutic range, 
varied from 0.3% to 100%. Wulf and Wettermark [23] studying 
PHA stimulated leukocytes reported similar alterations of cell 
t urnover depending on the 8-MOP concentrations. 
We found that long-term cell smvival was predictable from 
the alteration of DNA synthesis measmed in the first 2 hr after 
treatment of the cells with 8-MOP followed by UV-A, irrespec-
tive of the 8-MOP concentration (Fig 9). Thus DNA synthesis 
of 65-70% of the control value or greater was associated with 
virtually normal sw-vival, while DNA synthesis of less than 50% 
of the control value was associated with less than 10% smvival. 
There was a similar threshold value for DNA crosslink detec-
tion occurring with DNA synthesis less than 50% of t he control 
value. This suggests that DNA crosslinks are associated with 
lethali ty. Our previous study [9] detected a greater than 50% 
reduction in DNA synthesis in circulating leukocytes of pso-
TABLE II. Sister chromatid exchanges (SCE) induced by 8-MOP plus UV-A in human blood lymphocytes 
Treatment SCE's per metaphase SCE's per chromo- Metaphase freq uency 
8-MOP (J.!g/ ml) UV-A (J i m' ) Range Mean± SE some First division Second division Third division 
0 0 7-14 10.4 ± 0.72 0.23 20% 60% 20% 
0 7,500 4-19 12.9 ± 0.86 0.28 30% 56% 14% 
0.01 0 7- 19 13.2 ± 0.96 0.29 36% 47% 17% 
0.01 7,500 9-25 17.3 ± 0.95 0.38 52% 34% 14% 
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TABLE III. Sister chromatid exchanges (SCE) induced by 8- MOP plus UV-A in human lymphoblastoid cells 
Treatment Average No. of SCE's per metaphase SCE's 
8-MOP UV-A (l"g/ ml) (J/ m") 
chromosomes per 
per metaphase Range Mean± SE chromosome 
0 0 91.0 10-31 21 .2 ± 1.61 0.23 
0 15,000 85.0 10-29 21.0 ± L12 0.25 
0.1 0 90.5 6-29 19.3 ± 1.36 0.21 
0.1 3,000 89.5 17-68 43.9 "± 3.40 0.49 
0.1 15,000 No Metaphases Detected 
riasis patients undergoing photochemotherapy when "HTdR 
incorporation was measured in blood samples taken immedi-
ately after UV-A. A similar reduction in DNA synthesis in 
leukocytes of photochemotherapy treated patients was reported 
by Friedmann and Rogers [10). If the in vitro data can be 
extrapolated to the in vivo situation, this would imply that a 
portion of the circulating leukocytes would be killed following 
8-MOP plus UV -A. In this regard Ortonne et al [24], and Haftek 
et al [25] reported decreased circulating E rosette forming cells 
and Dahl, Nyfors, and Brodthagen [26] observed a decrease in 
the percentage of peripheral blood neutrophils in psoriasis 
patients treated with 8-MOP plus UV-A. 
Retinoic acid derivatives have been reported to shorten the 
clinical course of photochemotherapy in psoriasis patients 
[27). Epstein [28] found that in hairless mice, retinoic acid 
inhibited ultraviolet-induced epidermal hyperplasia as mea-
sured by autoradiographic assessment of 3HTdR incorporation. 
Kensler and Mueller [29] reported that retinoic acid, but not 13 
cis retinoic acid, was a potent inhibitor of the increased DNA 
synthesis induced by tetradecanoylphorbol acetate (TP A) plus 
PHA in bovine lymphocytes. Thus the mechanism of action of 
th e retinoids in psoriasis patients receiving photochemotherapy 
could involve a potentiation of the effects of 8-MOP plus UV -A 
on DNA synthesis or cell-survival. In our studies, however, with 
a short exposure to a single concentration of 13 cis-retinoic acid, 
in the presumed therapeutic r ange [30], no significant alteration 
in DNA synthesis (Fig lOA) or cell survival (Fig lOB) was 
observed in comparison to the values observed a fter treatment 
with 8-MOP, UV-A or both in the absence of the retinoic acid 
derivative. 
8-MOP plus UV -A treatment of human lymphoid cells in 
vitro has been shown to induce an increased rate of sister 
chromatid exchanges [31-36]. In the present study at most a 2-
fold increase in SCE's after 8-MOP plus UV-A (Tables II and 
III) , was found . In lymphocytes and lymphoblastoid cells, 8-
MOP pretreatment followed by UV~A exposure was associated 
with cell toxicity or mitotic delay as indicated by the smaller 
fraction of cells attaining second mitoses during the incubation 
period. With 0.1 JJ.g/ ml8-MOP pre-incubation, 15,000 J/m2 UV-
A followed by BrdU had an adverse effect on cell progression 
as indicated by the low number of second division meta phases 
seen in the lymphpblastoid cells. Thus, based on 50 metaphases, 
there was a very limited range of 8-MOP plus UV -A concentra-
tions in which increases in SCE could be detected; and the 
increase _in SCE frequency was relatively small. In contrast, 
treatment of lymphocytes with other DNA crosslinking agents 
may induce 'an increase in SCE to 5 times control value (mito-
mycin-C) (36], or to 10 times t he control value (busulfan) [37]. 
Thus in human lymphoid cells, SCE induction by 8-MOP plus 
UV -A is a relatively insensitive indicator of cell damage. Lam-
bert et al [33] demonstrated a 31% increase in SCE/cell when 
cells were removed from patients 2 hr after oral administration 
of 8-MOP subsequently exposed to 18,000 J/m2 UV-A. Wolf-
Schreiner et a1 [35] found a 34% increase in SCE/c;ell with a 
similar protocol using 10,500 J /m2 UV -A. Since circulating 
lymphocytes may have received less than 10,000 J/m2 UV-A, 
as discussed by Burger and Simons [38] the number of SCE 
induced per cell m ay be too low to be detected. Other studies, 
however, have documented alterations in circulating lymphoid 
cells of patients treated with 8-MOP plus UV -A. In this regard, 
Kraemer and Weinstein [9] and Friedmann and Rogers [10] 
detected decreased DNA synthesis of circulating leukocytes of 
some psoriasis patients undergoing photochemotherapy and 
Strauss et al [39] detected an increased frequency of thioguan-
ine resistant circulating lymphocytes during 8-MOP photo-
chemotherapy for vitiligo. 
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